Theratechnologies Gets Medical Review Committee Approval for Higher Doses of TH1902 at Phase 1b Trial

Theratechnologies 獲得醫療審查委員會批准在 10億試驗中使用更高劑量的 TH1902

MT Newswires · 2024/12/09 21:55

Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.

登入免費觀看全文

登入/註冊

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。更多信息

Theratechnologies Gets Medical Review Committee Approval for Higher Doses of TH1902 at Phase 1b Trial

Theratechnologies Gets Medical Review Committee Approval for Higher Doses of TH1902 at Phase 1b Trial

風險及免責聲明

聲明